Antiviral drug allergy.
Milpied-Homsi B, Moran EM, Phillips EJ.
Immunol Allergy Clin North Am · research-article; review; journal article · DOI 10.1016/j.iac.2014.04.011 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för etravirine. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
14 träffarCost-effectiveness of combination therapy with etravirine in treatment-experienced adults with HIV-1 infection.
Mauskopf J, Brogan AJ, Talbird SE, Martin S.
AIDS · clinical trial, phase iii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1097/qad.0b013e32834e87e6Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients.
Gutiérrez-Valencia A, Martin-Peña R, Torres-Cornejo A, Ruiz-Valderas R, Castillo-Ferrando JR, López-Cortés LF.
J Antimicrob Chemother · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dkr534Phase 2 double-blind, randomized trial of etravirine versus efavirenz in treatment-naive patients: 48-week results.
Gazzard B, Duvivier C, Zagler C, Castagna A, Hill A, Hill A, van Delft Y, Marks S.
AIDS · clinical trial, phase ii; comparative study; randomized controlled trial; journal article · DOI 10.1097/qad.0b013e32834c4c06Raltegravir dosage adjustment in HIV-infected patients receiving etravirine.
Do VT, Higginson RT, Fulco PP.
Am J Health Syst Pharm · journal article · DOI 10.2146/ajhp110083Effect of mutations at position E138 in HIV-1 reverse transcriptase on phenotypic susceptibility and virologic response to etravirine.
Tambuyzer L, Nijs S, Daems B, Picchio G, Vingerhoets J.
J Acquir Immune Defic Syndr · research support, non-u.s. gov't; journal article · DOI 10.1097/qai.0b013e3182237f74Short communication prevalence of susceptibility to etravirine by genotype and phenotype in samples received for routine HIV type 1 resistance testing in the United States.
Picchio G, Vingerhoets J, Tambuyzer L, Coakley E, Haddad M, Witek J.
AIDS Res Hum Retroviruses · research support, non-u.s. gov't; journal article · DOI 10.1089/aid.2011.0049Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis.
Tommasi C, Bellagamba R, Tempestilli M, D'Avolio A, Gallo AL, Ivanovic J, Nicastri E, Pucillo LP, Narciso P.
Malar J · research-article; journal article; case reports · DOI 10.1186/1475-2875-10-141Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimens.
Gupta S, Vingerhoets J, Fransen S, Tambuyzer L, Azijn H, Frantzell A, Paredes R, Coakley E, Nijs S, Clotet B, Petropoulos CJ, Schapiro J, Huang W, Picchio G.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.01695-10Pharmacokinetic interactions of maraviroc with darunavir-ritonavir, etravirine, and etravirine-darunavir-ritonavir in healthy volunteers: results of two drug interaction trials.
Kakuda TN, Abel S, Davis J, Hamlin J, Schöller-Gyüre M, Mack R, Ndongo N, Petit W, Ridgway C, Sekar V, Tweedy S, Hoetelmans RM.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1128/aac.01046-10Short communication: high effectiveness of etravirine in routine clinical practice in treatment-experienced HIV type 1-infected patients.
Santos JR, Llibre JM, Domingo P, Imaz A, Ferrer E, Podzamczer D, Bravo I, Ribera E, Videla S, Clotet B.
AIDS Res Hum Retroviruses · research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1089/aid.2010.0283Pharmacokinetic interactions between etravirine and non-antiretroviral drugs.
Kakuda TN, Schöller-Gyüre M, Hoetelmans RM.
Clin Pharmacokinet · research support, non-u.s. gov't; review; journal article · DOI 10.2165/11534740-000000000-00000Interaction potential of etravirine with drug transporters assessed in vitro.
Zembruski NC, Haefeli WE, Weiss J.
Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.01527-10Darunavir, ritonavir, and etravirine pharmacokinetics in the cervicovaginal fluid and blood plasma of HIV-infected women.
Patterson K, Jennings S, Falcon R, Mrus J, Kashuba A.
Antimicrob Agents Chemother · clinical trial, phase iii; research-article; multicenter study; journal article; research support, n.i.h., extramural · DOI 10.1128/aac.00889-10